- Home
- EU vs HQL Comparison
EU vs HQL Comparison
Compare EU & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EU | HQL |
|---|---|---|
| Founded | 2009 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Investment Managers |
| Sector | Basic Materials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 464.5M | 492.8M |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | EU | HQL |
|---|---|---|
| Price | $2.05 | $16.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 3.0M | 128.1K |
| Earning Date | 06-09-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.56% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | ★ $58,334,000.00 | N/A |
| Revenue This Year | $17.41 | N/A |
| Revenue Next Year | $95.45 | N/A |
| P/E Ratio | ★ N/A | $20.09 |
| Revenue Growth | ★ 163.38 | N/A |
| 52 Week Low | $1.01 | $10.55 |
| 52 Week High | $4.19 | $17.80 |
Technical Indicators
Market Signals| Indicator | EU | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 33.44 | 51.24 |
| Support Level | N/A | $16.40 |
| Resistance Level | $2.56 | $17.51 |
| Average True Range (ATR) | 0.18 | 0.29 |
| MACD | -0.06 | -0.03 |
| Stochastic Oscillator | 23.04 | 58.56 |
Price Performance
Historical ComparisonAbout EU enCore Energy Corp.
enCore Energy Corp together with its subsidiary, is engaged in the acquisition and exploration of resource properties of uranium resource properties in the United States. The holds a portfolio of uranium assets located in New Mexico, South Dakota, Wyoming, Texas, Utah, Colorado, and Arizona in the USA, and is advancing its properties with a focus on utilizing in-situ recovery. The company's Projects are South Texas Operations, Dewey-Burdock Project, Gas Hills Project, Crownpoint & Hosta Butte Project, PFN (Prompt Fission Neutron) Technology, and Other Assets.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.